Lipocine Inc. (LPCN)
NASDAQ·Healthcare·Biotechnology
$2.35
+2.17%
Mkt Cap $43.75M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (3 analysts)
$10.50
Range $6.00 – $15.00
Implied Upside
+346.8%
Consensus $10.50 vs current $2.35
NASDAQ·Healthcare·Biotechnology
$2.35
+2.17%
Mkt Cap $43.75M
Buy
1
Hold
1
Sell
0
Price Target (3 analysts)
$10.50
Range $6.00 – $15.00
+346.8%
Consensus $10.50 vs current $2.35